| 000 | 00000nam 2200000za 4500 |
| 001 | 9.847520 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107153448 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 171121s2018 onca o f000 0 eng d |
|---|
| 020 | |a9780660239385|z9780660239392 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aNR16-173/2017E-PDF |
|---|
| 110 | 2 |aNational Research Council Canada. |
|---|
| 245 | 10|aAMVAD adjuvant for mucosal vaccines (L-11561) |h[electronic resource]. |
|---|
| 260 | |a[Ottawa] : |bNational Research Council Canada, |c[2018] |
|---|
| 300 | |a[2] p. : |bill. |
|---|
| 500 | |aIssued also in French under title: Adjuvant AMVAD pour vaccins muqueux (L-11561). |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |a"January 2017." |
|---|
| 520 | |a“The NRC has developed a novel archaeal polar lipid mucosal vaccine adjuvant and delivery (AMVAD) platform capable of generating mucosal and systemic immune responses against a wide range of pathogens that infect mucosal surfaces or use them to gain entry to the body”--Highlights, p. [1]. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 693 | 4|aImmunological adjuvants |
|---|
| 693 | 4|aLiposomes |
|---|
| 775 | 08|tAdjuvant AMVAD pour vaccins muqueux (L-11561) |w(CaOODSP)9.847522 |
|---|
| 776 | 0#|tAMVAD adjuvant for mucosal vaccines |w(CaOODSP)9.847521 |
|---|
| 856 | 40|qPDF|s166 KB|uhttps://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-173-2017-eng.pdf |
|---|